ArticleEuropean journal of clinical pharmacology2022

JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study.

Amandine Gouverneur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.